Acadia Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
18.28
+1.78 (10.79%)
At close: Nov 10, 2026, 4:00 PM EST
18.00
-0.28 (-1.53%)
After-hours: Nov 10, 2026, 7:30 PM EST

Acadia Pharmaceuticals Revenue

Acadia Pharmaceuticals had revenue of $342.29M in the quarter ending September 30, 2026, with 22.85% growth. This brings the company's total for the last twelve months to $1.20B, up 14.82% year-over-year. In the year 2025, Acadia Pharmaceuticals had annual revenue of $1.07B with 11.87% growth. That makes Acadia Pharmaceuticals the 6,868th largest company in the world by revenue and 1,673rd in the United States.

Revenue (ttm)
$1.20B
Revenue Growth
+14.82%
P/S Ratio
2.63
Revenue / Employee
$1,506,643
Employees
798
Market Cap
3.16B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.07B113.71M11.87%
Dec 31, 2024957.80M231.36M31.85%
Dec 31, 2023726.44M209.20M40.45%
Dec 31, 2022517.24M33.09M6.83%
Dec 31, 2021484.15M42.39M9.60%
Dec 31, 2020441.76M102.68M30.28%
Dec 31, 2019339.08M115.27M51.50%
Dec 31, 2018223.81M98.91M79.19%
Dec 31, 2017124.90M107.57M620.68%
Dec 31, 201617.33M17.27M28,311.48%
Dec 31, 201561.00K-59.00K-49.17%
Dec 31, 2014120.00K-1.03M-89.52%
Dec 31, 20131.15M-3.76M-76.67%
Dec 31, 20124.91M2.84M137.40%
Dec 31, 20112.07M-40.07M-95.09%
Dec 31, 201042.14M35.74M558.46%
Dec 31, 20096.40M4.81M302.45%
Dec 31, 20081.59M-5.97M-78.95%
Dec 31, 20077.56M-578.00K-7.11%
Dec 31, 20068.13M-2.82M-25.77%
Dec 31, 200510.96M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Telix Pharmaceuticals890.79M
ADMA Biologics519.15M
Zai Lab441.73M
Vericel324.17M
Xencor200.49M
Beam Therapeutics146.64M
Arcus Biosciences100.00M
IDEAYA Biosciences36.54M
Revenue Rankings